Fierce Biotech July 26, 2022
Conor Hale

“You can’t get away from yourself by moving from one place to another,” Ernest Hemingway wrote nearly a century ago in his book “The Sun Also Rises,” as two men consider jumping continents to escape their troubles. In this digital century, where you can post from nearly anywhere, that phrase could be updated to: “You can’t escape your own personal brand.”

But in Martin Shkreli’s case, it appears he doesn’t even want to try. Two months fresh out of prison—and despite a federal judge banning the famous “pharma bro” from working in the drug industry for the rest of his life—he’s looking to get right back in the mix, and this time he’s hyping the blockchain.
...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Blockchain, Pharma, Pharma / Biotech, Technology
The Pharmacy Model Is Changing
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
The financial burden of drug shortages: 7 study takeaways
What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices

Share This Article